Status:
RECRUITING
Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease
Lead Sponsor:
University Hospital, Essen
Conditions:
Dementia, Alzheimer Type
Mild Cognitive Impairment
Eligibility:
All Genders
18+ years
Brief Summary
This study seeks to explore the possible common pathogenesis of both cardiac amyloidosis and Alzheimer's disease, which can both be associated with amyloid deposits. Using Positron Emission Tomography...
Eligibility Criteria
Inclusion
- Patients undergoing cerebral amyloid PET examination for clinical indication to clarify Alzheimer's disease
- No contraindications to undergo an MRI examination
- No contraindications to undergo an Amyloid PET scan
Exclusion
- Patients with vascular dementia and confirmed other causes of dementia (e.g. stroke, vitamin deficiency, thyroid insufficiency, toxic causes such as alcohol)
- Patients with pronounced cardiac preconditions
- Pregnant and breastfeeding women
Key Trial Info
Start Date :
August 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 14 2025
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT07154394
Start Date
August 15 2022
End Date
September 14 2025
Last Update
September 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Essen
Essen, North Rhine-Westphalia, Germany, 45147